82 results
8-K
EX-99.1
AGRX
Agile Therapeutics Inc
15 May 24
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
4:15pm
unrealized gains or losses pertaining to liability classified warrants. We believe that the presentation of these non-GAAP financial metrics provides useful
8-K
EX-99.1
AGRX
Agile Therapeutics Inc
28 Mar 24
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
9:06am
unrealized gains or losses pertaining to liability classified warrants and one-time non-cash charges incurred in connection with the loss on disposition
8-K
EX-99.1
gqb7lb9rbv2t vcb
9 Nov 23
Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
8:15am
8-K
EX-99.1
j031yrejqxozw94i6
9 Aug 23
Agile Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
8:10am
S-8
EX-99.1
7ql8qm wvu
9 Jun 23
Registration of securities for employees
5:19pm
424B4
xnrgk6oo
24 May 23
Prospectus supplement with pricing info
4:05pm
8-K
EX-99.1
2mjeoh undfbxlt
11 May 23
Agile Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:15pm